MedPath

Scalp Block Versus General Anesthesia in Patients Undergoing Evacuation of Subdural Hematoma Via Burr Hole

Not Applicable
Recruiting
Conditions
Subdural Hematoma
Interventions
Other: scalp block
Registration Number
NCT07143799
Lead Sponsor
Sohag University
Brief Summary

this study amis to compare between Scalp block versus general anesthesia in patients undergoing evacuation of subdural hematoma via burr hole.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria
  • Patients with a history of known sensitivity to study drugs.
  • Glasgow Coma Scale (GCS) <8
  • Impaired coagulation profile.
  • Any degree of heart block.
  • Infection at site of injection

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
'Group A will receive general anesthesiaCisatracuriumInduction of general anesthesia will be done by IV propofol 2-2.5 mg / kg and IV fentanyl lug/kg. After IV Cis-atracurium 0.15mg/kg, endotracheal intubation will be done.
Group B patients will receive scalp blockscalp blockThe scalp block will target six pairs of sensory nerves that innervate the scalp: the supraorbital nerve, supratrochlear nerve, auriculotemporal nerve, zygomaticotemporal nerve, greater occipital nerve, and lesser occipital nerve.Local anesthetic (2% lidocaine and bupivacaine) will be infiltrated at specific anatomical landmarks corresponding to the course of each nerve
Primary Outcome Measures
NameTimeMethod
The aim of this prospective randomized study is to compare Scalp block versus general anesthesia in patients undergoing evacuation of subdural hematoma via burr hole.24 hours after operation

Post operative scale by The Glasgow Coma Scale (GCS) and post operative hemodynamics.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sohag university hospital

🇪🇬

Sohag, Egypt

Sohag university hospital
🇪🇬Sohag, Egypt
Magdy M Amin, Professor
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.